Disorders of chloriuretic hormone secretion.
Experimental evidence supports the existence of a circulating substance, natriuretic hormone, which augments electrolyte excretion. Because such a hormone probably acts by inhibiting chloride reabsorption in the thick, ascending limb of the loop of Henle it would more accurately be called chloriuretic hormone. Chloriuretic hormone must have an action which resembles that of loop diuretics such as frusemide and ethacrynic acid. An excess of chloriuretic hormone could explain all the manifestations of Bartter's syndrome, whereas a deficiency could account for Gordon's syndrome. Hyporeninaemic hypoaldosteronism may develop in subjects who are unable to increase chloriuretic hormone concentrations appropriately in response to progressive impairment of renal function.
D000450:Aldosterone / Q000172:deficiency; D000804:Angiotensin II / Q000378:metabolism; D001477:Bartter Syndrome / Q000209:etiology*; D001688:Biological Products / Q000378:metabolism*; D001920:Bradykinin / Q000378:metabolism; D002712:Chlorides / Q000652:urine*; D006801:Humans; D006929:Hyperaldosteronism / Q000209:etiology*; D007610:Kallikreins / Q000652:urine; D008138:Loop of Henle / Q000378:metabolism; D009318:Natriuresis; D011188:Potassium / Q000378:metabolism; D011458:Prostaglandins E / Q000378:metabolism; D011504:Protein-Losing Enteropathies / Q000209:etiology*; D012083:Renin / Q000172:deficiency; D012964:Sodium / Q000378:metabolism; D013577:Syndrome
D001688:Biological Products; D002712:Chlorides; D011458:Prostaglandins E; D000804:Angiotensin II; D000450:Aldosterone; D012964:Sodium; D007610:Kallikreins; D012083:Renin; D011188:Potassium; D001920:Bradykinin